Activation of mucosal mast cells promotes inflammation-related colon cancer development through recruiting and modulating inflammatory CD11b+Gr1+ cells

Cancer Letters

Volumn 364, Issue 2, 2015, Pages 173-180

  Xu, Lingzhi ^a   Yi, Hong Gan ^a   Wu, Zhiyuan ^a   Han, Wenxiao ^a   Chen, Kun ^a   Zang, Mengya ^a   Wang, Dongmei ^a   Zhao, Xinhua ^a   Wang, Hongying ^a   Qu, Chunfeng ^a  

^a CANCER HOSPITAL   (China)

Author keywords

CD11b+Gr1+ cells; Colitis related colon cancer; Mouse mast cell protease 1; Mucosal mast cells

Indexed keywords

CD11B ANTIGEN; CHYMASE; CHEMOKINE RECEPTOR; GR-1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL COUNT; CELL GROWTH; CELL INFILTRATION; CELLULAR DISTRIBUTION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; INFLAMMATION; INFLAMMATORY CELL; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR MICROENVIRONMENT; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; COLITIS; COLON TUMOR; IMMUNOLOGY; INTESTINE MUCOSA; PATHOLOGY;

MURINAE; MUS;

ANIMALS; ANTIGENS, CD11B; COLITIS; COLONIC NEOPLASMS; INTESTINAL MUCOSA; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, CHEMOKINE; TUMOR MICROENVIRONMENT;

EID: 84930091931     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.05.014     Document Type: Article

References (38)

1. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
2. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
3. Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009, 30:1073-1081.
4. Echtenacher B., Mannel D.N., Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996, 381:75-77.
5. Malaviya R., Ikeda T., Ross E., Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996, 381:77-80.
6. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol 2005, 23:749-786.
7. Schreiber R.D., Old L.J., Smyth M.J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011, 331:1565-1570.
8. Acikalin M.F., Oner U., Topcu I., Yasar B., Kiper H., Colak E. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Dig. Liver Dis 2005, 37:162-169.
9. Gulubova M., Vlaykova T. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. J. Gastroenterol. Hepatol 2009, 24:1265-1275.
10. Nielsen H.J., Hansen U., Christensen I.J., Reimert C.M., Brunner N., Moesgaard F. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J. Pathol 1999, 189:487-495.
11. Ogino S., Shima K., Baba Y., Nosho K., Irahara N., Kure S., et al. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis. Gastroenterology 2009, 136:1242-1250.
12. Quante M., Varga J., Wang T.C., Greten F.R. The gastrointestinal tumor microenvironment. Gastroenterology 2013, 145:63-78.
13. Grivennikov S.I., Wang K., Mucida D., Stewart C.A., Schnabl B., Jauch D., et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012, 491:254-258.
14. McDermott J.R., Bartram R.E., Knight P.A., Miller H.R., Garrod D.R., Grencis R.K. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:7761-7766.
15. Groschwitz K.R., Ahrens R., Osterfeld H., Gurish M.F., Han X., Abrink M., et al. Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:22381-22386.
16. Rigoni A., Colombo M.P., Pucillo C. The role of mast cells in molding the tumor microenvironment. Cancer Microenviron 2014, 10.1007/s1230-014-0152-8.
17. Gurish M.F., Austen K.F. Developmental origin and functional specialization of mast cell subsets. Immunity 2012, 37:25-33.
18. Kalesnikoff J., Galli S.J. New developments in mast cell biology. Nat. Immunol 2008, 9:1215-1223.
19. Khazaie K., Blatner N.R., Khan M.W., Gounari F., Gounaris E., Dennis K., et al. The significant role of mast cells in cancer. Cancer Metastasis Rev 2011, 30:45-60.
20. Friend D.S., Ghildyal N., Austen K.F., Gurish M.F., Matsumoto R., Stevens R.L. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype. J. Cell Biol 1996, 135:279-290.
21. Tanaka T., Ishikawa H. Mast cells and inflammation-associated colorectal carcinogenesis. Semin. Immunopathol 2013, 35:245-254.
22. Okayasu I., Ohkusa T., Kajiura K., Kanno J., Sakamoto S. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 1996, 39:87-92.
23. Melgar S., Karlsson A., Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol 2005, 288:G1328-G1338.
24. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98:694-702.
25. Tanaka T., Kohno H., Suzuki R., Yamada Y., Sugie S., Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003, 94:965-973.
26. Cox J.S., Altounyan R.E. Nature and modes of action of disodium cromoglycate (Lomudal). Respiration 1970, 27(Suppl.):292-309.
27. Greiner A.N., Meltzer E.O. Pharmacologic rationale for treating allergic and nonallergic rhinitis. J. Allergy Clin. Immunol 2006, 118:985-998.
28. Forbes E.E., Groschwitz K., Abonia J.P., Brandt E.B., Cohen E., Blanchard C., et al. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J. Exp. Med 2008, 205:897-913.
29. Huang B., Zhao J., Shen S., Li H., He K.L., Shen G.X., et al. Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res 2007, 67:4346-4352.
30. Davies M.D., Parrott D.M. Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine. Gut 1981, 22:481-488.
31. Baronzio G., Schwartz L., Kiselevsky M., Guais A., Sanders E., Milanesi G., et al. Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesis. Anticancer Res 2012, 32:405-414.
32. Qu C., Edwards E.W., Tacke F., Angeli V., Llodra J., Sanchez-Schmitz G., et al. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J. Exp. Med 2004, 200:1231-1241.
33. Artis D., Humphreys N.E., Potten C.S., Wagner N., Muller W., McDermott J.R., et al. Beta7 integrin-deficient mice: delayed leukocyte recruitment and attenuated protective immunity in the small intestine during enteric helminth infection. Eur. J. Immunol 2000, 30:1656-1664.
34. Ren S.R., Xu L.B., Wu Z.Y., Du J., Gao M.H., Qu C.F. Exogenous dendritic cell homing to draining lymph nodes can be boosted by mast cell degranulation. Cell. Immunol 2010, 263:204-211.
35. Andersson M.K., Pemberton A.D., Miller H.R., Hellman L. Extended cleavage specificity of mMCP-1, the major mucosal mast cell protease in mouse-high specificity indicates high substrate selectivity. Mol. Immunol 2008, 45:2548-2558.
36. Gounaris E., Erdman S.E., Restaino C., Gurish M.F., Friend D.S., Gounari F., et al. Mast cells are an essential hematopoietic component for polyp development. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:19977-19982.
37. Danelli L., Frossi B., Gri G., Mion F., Guarnotta C., Bongiovanni L., et al. Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment. Cancer Immunol. Res 2015, 3:85-95.
38. Elenkov I.J., Webster E., Papanicolaou D.A., Fleisher T.A., Chrousos G.P., Wilder R.L. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J. Immunol 1998, 161:2586-2593.